Aadhaar details, doctors' prescription now mandatory for buying two COVID-19 drugs in Maharashtra
New Delhi | Jagran News Desk: To curb the black marketing of experimental COVID-19 drugs, the Maharashtra Food and Drug Administration on Friday made it mandatory for the family members of a positive coronavirus patient to produce Aadhaar details, doctors’ prescription, consent form, a COVID positive report and contact details to buy the anti-viral drug Remdesivir and anti-inflammatory medicine tocilizumab.
Food and Drug Administration (FDA) Minister Rajendra Shingne said that the regulatory authority is investigating whether the hospitals are hoarding the experimental drugs after procuring them directly from the manufacturers.
He also said that the decision to make these documents mandatory was taken after complaints of shortage and concerns over the black marketing of these experimental drugs.
“We have received information that people who do not need the drug are trying to purchase it and then selling it at an inflated rate,” the minister said as reported by Times of India.
“These documents will now have to be produced by people buying it from druggists. This will help us track the sale and use of these drugs”, the minister added.
However, some doctors in the state expressed concerns over the decision and said that demanding so many documents from the distressed kin of positive coronavirus patients is unfair and will only make their struggle to get these medics worse.
The FDA minister made surprise checks at Masina Hospital in Byculla and a store of a wholesale druggist, SK Distributor, in Ghatkopar after several videos going viral in which hundreds of people thronging the wholesale drug store in Ghatkopar surfaced online on Thursday.
However, the FDA officials accompanying the minister said that they did not find any disparity in the sale and purchase of these drugs at these places.
“Since these drugs may have shown encouraging results on critical Covid-19 patients, their demand has gone up in the last few weeks,” Shingne said as quoted by Times of India, adding “we have asked the licensed companies to expedite production.”
An FDA official, as reported by Times of India said that around 2,100 vials of the anti-viral drug Remdesivir arrived in Mumbai on Thursday, of which 1,600 vials were sent to private hospitals while the remaining 500 went to the hospitals managed by Brihannmumbai Municipal Corporation (BMC).
Posted By: Talib Khan